维普中文期刊产品整合服务

New insights into the pathogenesis of Peyronie’s disease:A narrative review

查看全文 作  者:Denis [1]V.Krakhotkin;Volodymyr [2]A.Chernylovskyi;Alexandre [3,4]Mottrie;Francesco [5]Greco;Ruslan [1]A.Bugaev 高影响力作者 机构地区:[1]Outpatient Department,Central District Hospital,Kamenolomni,Rostov Region.Russia;[2]Department of Urology 1,City Clinical Hospital No-4,Dnipro,Ukraine;[3]Department of Urology,Onze Li eve Vrouw Hospital,Aalst,Belgium;[4]ORSI Academy,Me lie,Belgium;[5]Department of Urology,Humanitas Gcivazzeni,Bergamo,Italy高影响力机构 出  处:《Chronic Diseases and Translational Medicine》索引2020年第6卷第3期,共17页高影响力期刊 摘  要:Peyronie’s disease(PD)is a benign,progressive fibrotic disorder characterized by scar or plaques within the tunica albuginea(TA)of the penis.This study provides new insights into the pathogenesis of PD based on data from different studies regarding the roles of cytokines,cell signaling pathways,biochemical mechanisms,genetic factors responsible for fibrogenesis.A growing body of literature has shown that PD is a chronically impaired,localized,wound healing process within the TA and the Smith space.It is caused by the influence of different pathological stimuli,most often the effects of mechanical stress during sexual intercourse in genetically sensitive individuals with unusual anatomical TA features,imbalanced matrix metalloproteinase/tissue inhibitor of metalloproteinase(MMP/TIMP),and suppressed antioxidant systems during chronic inflammation.Other intracellular signal cascades are activated during fibrosis along with low expression levels of their negative regulators and transforming growth factor-β1 signaling.The development of multikinase agents with minimal side effects that can block several signal cell pathways would significantly improve fibrosis in PD tissues by acting on common downstream mediators. 关 键 词:Peyronie’s disease Cell signal pathway Penile curvature MYOFIBROBLAST Extracellular matrix
相关文献

参考文献(144)

耦合文献(23)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费